Forbes Revalues Elizabeth Holmes’ Net Wealth At Zero
Two years ago, private investors purchased stakes in Elizabeth Holmes’ blood testing start-up Theranos, at a price that implied a $9 billion valuation for the company. This share-shuffling meant that Holmes, who owns 50% of Theranos, saw her private wealth spike to $4.5 billion, a figure which put her on top of the FORBES list of America’s Richest Self-Made Women.
However, over the past 12 months, Holmes’ position at the head of this list has been called into question repeatedly as Theranos has been hit by a wave of allegations that its tests are inaccurate and is now being investigated by a number of federal agencies.
